The Cooper Companies, Inc. $COO Shares Bought by Citigroup Inc.

Citigroup Inc. grew its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 85.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 333,921 shares of the medical device company’s stock after acquiring an additional 153,572 shares during the period. Citigroup Inc. owned about 0.17% of Cooper Companies worth $22,894,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also modified their holdings of the stock. Buckhead Capital Management LLC grew its position in shares of Cooper Companies by 14.3% during the third quarter. Buckhead Capital Management LLC now owns 58,930 shares of the medical device company’s stock worth $4,040,000 after buying an additional 7,368 shares in the last quarter. First American Bank purchased a new position in Cooper Companies in the third quarter worth approximately $1,646,000. Rakuten Investment Management Inc. acquired a new position in Cooper Companies during the 3rd quarter worth approximately $11,341,000. Amundi increased its position in shares of Cooper Companies by 35.5% in the 2nd quarter. Amundi now owns 1,331,480 shares of the medical device company’s stock valued at $97,225,000 after purchasing an additional 348,652 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA raised its holdings in shares of Cooper Companies by 96.9% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,099,750 shares of the medical device company’s stock valued at $212,519,000 after purchasing an additional 1,525,693 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Trading Up 0.6%

NASDAQ:COO opened at $84.01 on Friday. The company has a market capitalization of $16.39 billion, a PE ratio of 44.69, a P/E/G ratio of 2.38 and a beta of 1.03. The Cooper Companies, Inc. has a 52-week low of $61.78 and a 52-week high of $92.84. The stock’s 50 day moving average price is $82.25 and its 200 day moving average price is $75.61. The company has a quick ratio of 1.13, a current ratio of 1.89 and a debt-to-equity ratio of 0.30.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Thursday, December 4th. The medical device company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.04. The business had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.06 billion. Cooper Companies had a return on equity of 10.02% and a net margin of 9.16%.The company’s revenue was up 4.6% compared to the same quarter last year. During the same period in the prior year, the company earned $1.04 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. On average, research analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Insider Buying and Selling

In related news, Director Maria Rivas purchased 1,000 shares of the stock in a transaction that occurred on Thursday, December 18th. The shares were purchased at an average price of $82.13 per share, with a total value of $82,130.00. Following the completion of the acquisition, the director directly owned 11,141 shares in the company, valued at $915,010.33. This represents a 9.86% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Lawrence Erik Kurzius acquired 2,000 shares of Cooper Companies stock in a transaction on Wednesday, December 17th. The shares were bought at an average cost of $82.50 per share, with a total value of $165,000.00. Following the completion of the purchase, the director owned 7,777 shares in the company, valued at $641,602.50. The trade was a 34.62% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired a total of 16,014 shares of company stock valued at $1,304,416 in the last quarter. Corporate insiders own 1.98% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on COO shares. JPMorgan Chase & Co. boosted their target price on shares of Cooper Companies from $66.00 to $78.00 and gave the stock a “neutral” rating in a research note on Friday, December 5th. The Goldman Sachs Group reaffirmed a “sell” rating and set a $73.00 price target on shares of Cooper Companies in a report on Friday, January 9th. Piper Sandler reaffirmed an “overweight” rating and set a $94.00 price objective (up from $83.00) on shares of Cooper Companies in a research report on Friday, December 5th. Robert W. Baird raised their target price on Cooper Companies from $85.00 to $98.00 and gave the stock an “outperform” rating in a research report on Friday, December 5th. Finally, Barclays set a $98.00 target price on Cooper Companies and gave the stock an “overweight” rating in a research note on Monday, January 26th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $90.77.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.